3F8 is a selective GSK-3beta inhibitor that can be used as a new tool and potential therapeutic candidate compound for GSK3-related diseases, and can be used in the study of neurological disorders and cancer.
Molekulargewicht:
286.28
Reinheit:
98.49%
CAS Nummer:
[159109-11-2]
Formel:
C15H14N2O4
Target-Kategorie:
GSK-3
T22180
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten